NEW YORK (GenomeWeb) – Israeli ag-bio firm NRGene has signed a deal with Illumina to co-market its proprietary de novo assembly informatics technology DeNovoMAGIC with Illumina's sequencers, the company announced today.

Illumina's sequencing technology is the fastest and most practical way to assemble complex genomes such as those of most crop and livestock species, NRGene said in a statement. In fact, the company has assembled various lines of wheat, maize, soy, forestry and fruit trees, and fish, among other organisms, the statement added.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.